Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Why Botox collaboration, not daxxify?
How much sales do you predict? Do you think CD will sell much more?
Went to injection today. Doctor told me daxxify only last a little bit longer than Botox, so isn’t that much popular. The injection is the same as Botox, no need to get special training.
Ordered daxxify injection today.
880$ to cover the whole face, maybe just 300$ to cover one area. Pretty affordable for all ladies.
Everywhere is fully lined up and busy (including all neurotoxins).
I don’t understand why they need to spend 450m per year. Just cut cost to 300m.
I really believe the competitors are behind this.
If allergen short rvnc to 2$, rvnc can’t raise money and will run out of cash.
Are you seeing much more instagram posts recently? Hopefully the growth is exponential.
What if rvnc run out of cash, and share prices stay too low to get dilution?
A customer has to be blind to choose Eols. It is the same thing as Botox. The only advantage is it has been advertised many more years.
So not twice longer, just maybe one month longer and less side effects. That still worth switching.
A little bit higher price is a good sales strategy. That is equal as saying “this is better”. 20% more is nothing.
How do you know they are “new”?
Share holders should protect your shares from short attacks. Set a sell limit order with a very high price (for instance 100$), so that others can’t borrow your shares to short.
Is this Botox or daxify?
I believe China market too. A large population of upper middle class (5 times US population), fast pace in everything, and no allergen keep bashing.
When will China be approved? I think new market has better potential than existing markets, where rvnc needs to take over market shares from allergen.
If both daxxi and Botox are new, I don’t see any reason a customer will choose Botox.
Is the company lying or hiding something?
I thought all trials are completed and data is ready to go. Why they need a higher dose?